Scholars Central

Conference abstractPublished 29 Mar 2016

A practical example of model-based biomarker discovery by quantitative proteomics

Authors: Kian Kani

University of Southern California, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The first documented case of cancer dates back to the Egyptians in 1600 BCE. A number of seminal discoveries since the ancient Egyptians have redefined our understanding of cancer. In fact, over the past several years, Cancer researchers have begun to reclassify tumors based on the molecular signalling pathways that cause malignant transformation. As a result, medical oncologists can prescribe drugs that specifically target the aberrant signalling pathway irrespective of the location of the Tumor. Modern cancer therapeutics is becoming targeted rather than systemic. This has brought upon a significant paradigm shift in medical treatment decisions and spurred the precision medicine era. Cancer cells must maintain a malleable phenotype in order to adapt to the selective pressures of the microenvironment and therapeutics. The cellsâÂ?Â? ability to modulate its proteome in the context of these selective pressures is an essential component of Tumor progression. Yet, to date, there has not been a systematic evaluation of the proteomic landscape associated with cancer progression, response to therapy and or resistance. We have demonstrated that the proteome of cancer cells which are sensitive to EGFR targeted drugs are quantitatively different from resistant cells. The shift from a sensitive to resistant phenotype was accompanied by a dramatic shift in the proteome. This finding suggests that cancer cells are able to rapidly alter their proteome signature in order to adapt to a selective pressures. Since the signature of resistant cells is different than the parental precursors, the possibility of discovering unique biomarkers of resistance is a reality.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Proteomics & Bioinformatics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Proteomics & Bioinformatics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Kian Kani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels